How would you approach systemic treatment of oligometastatic recurrence following surgical removal of the single area of metastases in a patient with ER+ (20-30%), PR-negative, HER2-negative breast cancer?

Oligometastatic recurrence occurred 10 years since initial breast cancer diagnosis and was a single pulmonary nodule.